Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-02-12 00:00:00 ET · period of report 2025-02-10 · accession 0001510281-25-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-02-12 | 2025-02-10+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $13.89 | -62.7K | 3.31M | -2% | -$871.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-10 | S | D | 42,987 | $13.95 | 3,332,473 | I - | — | — | |
| 2 | Common | Common Stock | 2025-02-11 | S | D | 19,756 | $13.77 | 3,312,717 | I - | — | — |